`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`ACTAVIS LLC,
`Petitioner,
`
`v.
`
`ABRAXIS BIOSCIENCE, LLC,
`Patent Owner.
`_____________
`
`Case IPR2017-01103
`Patent 7,923,536
`_____________
`
`PATENT OWNER’S MANDATORY NOTICES
`
`
`
`
`
`
`
`
`
`
`Case IPR2017-01103
`Patent 7,923,536
`Patent Owner Mandatory Notices
`
`Abraxis BioScience, LLC, the Patent Owner, provides the following
`
`
`
`mandatory notices pursuant to 37 C.F.R. § 42.8.
`
`REAL PARTY-IN-INTEREST
`
`In accordance with 37 C.F.R. § 42.8(b)(1), Patent Owner identifies Abraxis
`
`Biosciences, LLC (“Abraxis”) and Celgene Corporation (“Celgene”) as real
`
`parties-in-interest. Celgene is a corporation organized and existing under the laws
`
`of the State of Delaware, having a principal place of business at 86 Morris Avenue,
`
`Summit, New Jersey 07901. Abraxis is a wholly owned subsidiary of Celgene.
`
`Abraxis, a corporation organized and existing under the laws of the State of
`
`Delaware, having a principal place of business at 11755 Wilshire Boulevard, 20th
`
`Floor, Los Angeles, California 90025, is the owner of all right, title and interest in
`
`U.S. Patent No. 7,923,536 (“the ’536 Patent”) by virtue of an assignment from the
`
`inventors, Neil P. Desai, Patrick Soon-Shiong, and Vuong Trieu. The Assignment
`
`was recorded on January 26, 2011 at Reel 025703, Frame 0300.
`
`RELATED MATTERS
`
`Pursuant to 37 C.F.R. § 42.8(b)(2), Patent Owner identifies the following:
`
`A.
`
`Proceedings Before the USPTO Involving Related Patents
`
`• The ’536 Patent, which issued from U.S. Application Serial No.
`
`12/758,413, is a continuation of the U.S. Application Serial No.
`
`
`
`
`
`
`
`11/553,339, which issued as U.S. Patent No. 7,820,788 (“the ’788
`
`Patent”). The ’788 Patent is the subject of IPR2017-001101.
`
`• U.S. Patent No. 8,138,229 (“the ’229 Patent”), which issued from U.S.
`
`Application Serial No. 12/910,693, is a continuation of U.S.
`
`Application Serial No. 11/553,339, which issued as the ’788 Patent.
`
`The ’229 Patent is the subject of IPR2017-01104.
`
`Litigations Involving the Patent-at-Issue
`
`B.
`The ’536 Patent is the subject of the following pending litigations:
`
`• Abraxis Bioscience, LLC et al v. Actavis, LLC, 2:16-cv-09074-JMV-
`
`MF (D.N.J. April 6, 2016).
`
`• Abraxis Bioscience, LLC et al v. Cipla Ltd., 2:16-cv-09074-JMV-MF
`
`(D.N.J. Dec. 7, 2016).
`
`II. LEAD AND BACKUP COUNSEL AND SERVICE INFORMATION
`In accordance with 37 C.F.R. §§ 42.8(b)(3), 42.8(b)(4), and 42.10(a), Patent
`
`Owner identifies the following lead and backup counsel and service information:
`
`J. Patrick Elsevier, Ph.D.(Reg. No. 44,668)
`Jones Day
`4655 Executive Drive, Suite 1500
`San Diego, CA 92121-3134
`
`Tel: (858) 314-1200
`Fax: (844) 345-3178
`Email: jpelsevier@jonesday.com
`
`-2-
`
`Lead counsel:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Backup counsel:
`
`
`Anthony M. Insogna (Reg. No. 35,203)
`Jones Day
`4655 Executive Drive, Suite 1500
`San Diego, CA 92121-3134
`
`Tel: (858) 314-1200
`Fax: (844) 345-3178
`Email: aminsogna@jonesday.com
`
`Lisamarie LoGiudice, Ph.D. (Reg. No.
`71,047)
`Jones Day
`250 Vesey Street
`New York, NY 10281-1047
`Tel: (212) 326-3939
`Fax: (212) 755-7306
`Email: llogiudice@jonesday.com
`
`Andrew S. Chalson (pro hac vice)
`Quinn Emanuel Urquhart & Sullivan,
`LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7112
`Fax: (212) 849-7100
`Email:
`andrewchalson@quinnemanuel.com
`
`
`Cary Miller, Ph.D. (Reg. No. 54,708)
`Jones Day
`4655 Executive Drive, Suite 1500
`San Diego, CA 92121-3134
`
`Tel: (858) 314-1200
`Fax: (844) 345-3178
`Email: cmiller@jonesday.com
`
`F. Dominic Cerrito (Reg. No. 38,100)
`Quinn Emanuel Urquhart & Sullivan,
`LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7112
`Fax: (212) 849-7100
`Email: nickcerrito@quinnemanuel.com
`
`Frank C. Calvosa (Reg. No. 69,064)
`Quinn Emanuel Urquhart & Sullivan,
`LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7112
`Fax: (212) 849-7100
`Email:
`frankcalvosa@quinnemanuel.com
`
`
`Patent Owner consents to electronic service by email.
`
`Pursuant to 37 C.F.R. § 42.10(b), a Power of Attorney is being submitted to
`
`the Board herewith.
`
`
`
`
`
`Respectfully submitted,
`
`-3-
`
`
`
`Dated: April 24, 2017
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/ J. Patrick Elsevier, Ph.D.
`J. Patrick Elsevier, Ph.D.
`(Reg. No. 44,668)
`
`Jones Day
` 4655 Executive Drive, Suite 1500
` San Diego, CA 92121-3134
` Tel: (858) 314-1200
` Fax: (844) 345-3178
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`-4-
`
`
`
`
`
`Case IPR2017-01103
`Patent 7,923,536
`Patent Owner Mandatory Notices
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), I certify that I caused to be served on the
`
`counsel for Petitioner a true and correct copy of the foregoing “Patent Owner’s
`
`Mandatory Notices” and the document captioned “Power of Attorney For
`
`Proceedings Before the Patent Trial and Appeal Board” by electronic means on
`
`April 24, 2017 at the following email addresses of record:
`
`Lead Counsel
`Samuel S. Park
`WINSTON & STRAWN LLP
`35 W. Wacker Drive
`Chicago, IL 60601
`AbraxaneIPR@winston.com
`Tel.: 312-558-7931
`Fax: 312-558-5700
`
`
`
`Backup Counsel
`George C. Lombardi
`Charles B. Klein
`Kevin E. Warner
`Eimeric Reig-Plessis
`WINSTON & STRAWN LLP
`35 W. Wacker Drive
`Chicago, IL 60601
`AbraxaneIPR@winston.com
`Tel.: 312-558-7931
`Fax: 312-558-5700
`
`Dated: April 24, 2017
`
`
`
`
`
`
`
`
`
`/s/ J. Patrick Elsevier, Ph.D.
`J. Patrick Elsevier, Ph.D.
`(Reg. No. 44,668)
`
`Jones Day
` 4655 Executive Drive, Suite 1500
` San Diego, CA 92121-3134
` Tel: (858) 314-1200
`Fax: (844) 345-3178
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`